Morgan Z Lin, MD
Cardiovascular Disease (Cardiology) · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 6
Offices
6 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A52480 · Current
Licensed to practise in California · since 1993 · expires 2027-06-30 · Institute of Medicine (I) Rangoon.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$472,606
Medicare paid this office $472,606 for 1,922 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 837 | $194,290 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $43,849 | $162 |
| Long return visit (40+ min) | 165 | $38,606 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $31,981 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $17,234 | $58 |
See all 28 services
| Return visit (30+ min) | 837 | $194,290 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $43,849 | $162 |
| Long return visit (40+ min) | 165 | $38,606 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $31,981 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $17,234 | $58 |
| Critical care, first 30-74 minutes | 37 | $15,988 | $182 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 708 | $15,648 | $15 |
| New patient visit (45+ min) | 98 | $14,265 | $146 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $13,449 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $9,252 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 848 | $8,485 | $7 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 54 | $7,404 | $54 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,568 | $469 |
| Short return visit (20+ min) | 80 | $6,452 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $4,792 | $184 |
| Programming of dual lead pacemaker system | 43 | $4,323 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 276 | $3,937 | $14 |
| New patient visit (60+ min) | 18 | $3,008 | $167 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 52 | $2,754 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 214 | $2,500 | $11 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 103 | $2,366 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 305 | $1,955 | $6 |
| Ultrasound of heart, follow-up | 54 | $1,378 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $840 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $415 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $365 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 51 | $347 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $289 | $12 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 24 | More than 56% of doctors who do this |
Who their Medicare patients are
1,922 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 22% · Women 54% · Also on Medicaid 23% · Health risk score 1.71. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Chronic kidney disease 45% · Coronary heart disease 43% · Diabetes 35% · Atrial fibrillation 31% · Heart failure 30% · Cancer 20% · Depression 20% · COPD 19% · Dementia 15% · Stroke 15%.
The office billed $3,115,450, Medicare allowed $649,619 and paid $472,606; for 7,561 services of 68 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,922 | 7,561 | 77 | 1.71 | $3,115,450 | $472,606 |
| 2023 | 1,755 | 6,237 | 77 | 1.63 | $2,753,334 | $418,301 |
| 2022 | 1,537 | 5,696 | 77 | 1.54 | $1,959,548 | $388,652 |
| 2021 | 1,402 | 5,863 | 77 | 1.58 | $1,934,652 | $437,103 |
| 2020 | 1,226 | 5,149 | 77 | 1.80 | $1,888,965 | $347,130 |
| 2019 | 1,350 | 4,638 | 77 | 1.73 | $1,549,041 | $333,431 |
| 2018 | 1,268 | 5,386 | 77 | 1.60 | $1,118,107 | $454,926 |
| 2017 | 1,411 | 5,957 | 77 | 1.66 | $1,124,583 | $475,473 |
| 2016 | 871 | 5,985 | 77 | 1.61 | $1,214,065 | $510,330 |
| 2015 | 1,267 | 6,026 | 77 | 1.74 | $1,104,835 | $477,739 |
| 2014 | 1,149 | 5,900 | 77 | 1.70 | $1,087,854 | $462,429 |
| 2013 | 1,327 | 5,711 | 77 | 1.68 | $996,480 | $409,670 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 31 services
| Return visit (30+ min) | 751 | $177,223 | $106 |
| Long return visit (40+ min) | 200 | $48,536 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $26,556 | $105 |
| Critical care, first 30-74 minutes | 39 | $19,263 | $183 |
| New patient visit (45+ min) | 116 | $16,457 | $142 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 273 | $15,784 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 244 | $14,360 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,016 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $11,967 | $68 |
| Short return visit (20+ min) | 94 | $7,034 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 719 | $6,709 | $7 |
| New patient visit (60+ min) | 32 | $4,923 | $154 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 52 | $4,884 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 69 | $4,820 | $70 |
| Programming of dual lead pacemaker system | 41 | $4,416 | $72 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,035 | $202 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $3,807 | $190 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 302 | $3,778 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 107 | $2,348 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $2,348 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 306 | $2,153 | $6 |
| Telehealth originating site facility fee | 59 | $1,635 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 113 | $1,284 | $11 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $959 | $31 |
| Ultrasound of heart, follow-up | 32 | $728 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 38 | $668 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 25 | $453 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $422 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $345 | $23 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 27 | $163 | $6 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 28 | $137 | $5 |
2022: 29 services
| Return visit (30+ min) | 676 | $165,907 | $105 |
| Long return visit (40+ min) | 157 | $37,264 | $159 |
| Critical care, first 30-74 minutes | 58 | $29,304 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $28,069 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 374 | $21,362 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,286 | $168 |
| New patient visit (45+ min) | 81 | $10,724 | $132 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $10,248 | $106 |
| Short return visit (20+ min) | 107 | $8,954 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,463 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 597 | $5,976 | $7 |
| New patient visit (60+ min) | 28 | $5,546 | $198 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 371 | $4,446 | $11 |
| Programming of dual lead pacemaker system | 38 | $4,002 | $70 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 42 | $3,214 | $23 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,107 | $194 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $3,094 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 188 | $2,267 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 46 | $2,004 | $23 |
| Initial hospital observation care per day, typically 70 minutes | 14 | $1,826 | $122 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 63 | $1,388 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 185 | $1,349 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,199 | $32 |
| Telehealth originating site facility fee | 38 | $854 | $21 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $548 | $46 |
| Heart rhythm recording of continous external ekg over 8-15 days | 38 | $533 | $14 |
| Ultrasound of heart, follow-up | 18 | $447 | $21 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $121 | $5 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $95 | $6 |
2021: 31 services
| Return visit (30+ min) | 658 | $179,660 | $115 |
| Long return visit (40+ min) | 155 | $39,103 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $29,100 | $93 |
| Critical care, first 30-74 minutes | 52 | $27,949 | $195 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 352 | $22,019 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $17,318 | $204 |
| New patient visit (45+ min) | 98 | $16,533 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $12,167 | $174 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,730 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $6,974 | $65 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 54 | $6,783 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 445 | $6,645 | $13 |
| Short return visit (20+ min) | 75 | $6,449 | $69 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,366 | $455 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 533 | $5,279 | $7 |
| New patient visit (60+ min) | 23 | $4,871 | $212 |
| Telephone medical discussion with physician, 11-20 minutes | 63 | $4,280 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 56 | $4,023 | $24 |
| Initial hospital observation care per day, typically 70 minutes | 25 | $3,991 | $160 |
| Programming of dual lead pacemaker system | 29 | $3,023 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $2,983 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 208 | $2,665 | $13 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,821 | $96 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 71 | $1,673 | $23 |
| Follow-up observation care per day, typically 35 minutes | 15 | $1,483 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $1,217 | $29 |
| Heart rhythm recording of continous external ekg over 8-15 days | 68 | $1,083 | $15 |
| Ultrasound of heart, follow-up | 23 | $650 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $474 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $189 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $125 | $7 |
2020: 32 services
| Return visit (30+ min) | 568 | $104,392 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $30,485 | $188 |
| Critical care, first 30-74 minutes | 57 | $28,435 | $186 |
| Long return visit (40+ min) | 141 | $28,293 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $23,192 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $14,651 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 141 | $11,424 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $10,028 | $164 |
| Short return visit (20+ min) | 121 | $9,162 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $9,035 | $61 |
| New patient visit (45+ min) | 67 | $8,760 | $131 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 49 | $7,855 | $23 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,093 | $435 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 306 | $5,211 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 402 | $4,066 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,061 | $203 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 47 | $3,887 | $81 |
| Programming of dual lead pacemaker system | 30 | $3,229 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $3,089 | $25 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,089 | $161 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $1,991 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 155 | $1,930 | $12 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,514 | $116 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,486 | $33 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,440 | $90 |
| External shock to heart to regulate heart beat | 11 | $1,308 | $93 |
| External ekg recording for more than 48 hours up to 21 days | 34 | $997 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 32 | $741 | $22 |
| Ultrasound of heart, follow-up | 21 | $467 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $461 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $123 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $101 | $6 |
2019: 29 services
| Return visit (30+ min) | 562 | $118,284 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $34,760 | $206 |
| Long return visit (40+ min) | 124 | $22,685 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $15,887 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 204 | $13,921 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $13,450 | $93 |
| Critical care, first 30-74 minutes | 37 | $13,312 | $196 |
| New patient visit (45+ min) | 70 | $10,617 | $152 |
| Short return visit (20+ min) | 146 | $10,188 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,361 | $182 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $6,494 | $433 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 318 | $5,801 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 521 | $5,299 | $8 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 55 | $5,033 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 38 | $4,248 | $24 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,432 | $123 |
| New patient visit (60+ min) | 16 | $2,917 | $182 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 15 | $2,907 | $97 |
| Programming of dual lead pacemaker system | 26 | $2,765 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,726 | $210 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 160 | $2,202 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $1,916 | $23 |
| Follow-up observation care per day, typically 25 minutes | 18 | $1,447 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,171 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,074 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $984 | $62 |
| Ultrasound of heart, follow-up | 12 | $375 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 37 | $298 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $286 | $11 |
2018: 33 services
| Return visit (30+ min) | 620 | $141,729 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 141 | $70,433 | $496 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 228 | $46,692 | $200 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 141 | $26,727 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $23,996 | $65 |
| Injection, regadenoson, 0.1 mg | 94 | $16,703 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $15,843 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $12,980 | $66 |
| New patient visit (45+ min) | 79 | $11,399 | $144 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 151 | $9,419 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $8,295 | $437 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $7,596 | $93 |
| Transitional care management services for problem of at least moderate complexity | 48 | $7,452 | $149 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 264 | $4,933 | $16 |
| Short return visit (20+ min) | 63 | $4,283 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 430 | $3,888 | $8 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,574 | $188 |
| Long return visit (40+ min) | 23 | $3,356 | $129 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,970 | $82 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,746 | $229 |
| Programming of dual lead pacemaker system | 30 | $2,486 | $53 |
| New patient visit (60+ min) | 16 | $2,384 | $149 |
| Return visit (30+ min) | 20 | $1,957 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 30 | $1,779 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 25 | $1,748 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,201 | $46 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $1,091 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 45 | $914 | $20 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 25 | $846 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 45 | $614 | $13 |
| Ultrasonic guidance for blood vessel access | 16 | $229 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $197 | $11 |
| Infusion, normal saline solution, 250 cc | 101 | $48 | None |
2017: 36 services
| Return visit (30+ min) | 594 | $144,816 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 163 | $80,095 | $482 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $39,185 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 151 | $27,889 | $63 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 164 | $22,517 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $17,706 | $177 |
| Injection, regadenoson, 0.1 mg | 100 | $17,698 | None |
| New patient visit (45+ min) | 89 | $12,456 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 164 | $10,720 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | $10,599 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $9,678 | $91 |
| Transitional care management services for problem of at least moderate complexity | 51 | $8,469 | $151 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,783 | $432 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $7,533 | $251 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 628 | $6,107 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 311 | $5,904 | $15 |
| Short return visit (20+ min) | 81 | $5,594 | $56 |
| Long return visit (40+ min) | 29 | $3,965 | $120 |
| Programming of dual lead pacemaker system | 42 | $3,522 | $53 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 42 | $3,521 | $80 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,154 | $197 |
| Critical care, first 30-74 minutes | 16 | $3,028 | $189 |
| New patient visit (60+ min) | 15 | $2,203 | $147 |
| Return visit (30+ min) | 21 | $1,716 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $1,372 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 20 | $931 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $896 | $28 |
| Hospital observation care on day of discharge | 13 | $841 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $704 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $472 | $13 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 18 | $421 | $12 |
| Ultrasonic guidance for blood vessel access | 25 | $313 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $235 | $11 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 17 | $210 | $12 |
| Injection, aminophyllin, up to 250 mg | 21 | $126 | None |
| Infusion, normal saline solution, 250 cc | 130 | $51 | None |
2016: 34 services
| Return visit (30+ min) | 565 | $129,915 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 149 | $75,205 | $473 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $46,753 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 189 | $38,899 | $62 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 149 | $30,342 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $24,167 | $174 |
| Injection, regadenoson, 0.1 mg | 88 | $15,932 | None |
| Long return visit (40+ min) | 81 | $12,246 | $126 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $12,184 | $249 |
| Transitional care management services for problem of at least moderate complexity | 70 | $11,747 | $149 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 152 | $9,957 | $61 |
| New patient visit (45+ min) | 71 | $9,699 | $137 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 165 | $9,385 | $55 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 42 | $9,364 | $213 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $9,150 | $482 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $7,591 | $89 |
| Initial hospital observation care per day, typically 70 minutes | 38 | $6,400 | $156 |
| Short return visit (20+ min) | 89 | $6,120 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 299 | $5,570 | $15 |
| Critical care, first 30-74 minutes | 17 | $4,353 | $189 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 46 | $3,620 | $79 |
| Programming of dual lead pacemaker system | 40 | $3,147 | $50 |
| Ultrasound of both sides of head and neck blood flow | 12 | $2,222 | $185 |
| Follow-up observation care per day, typically 25 minutes | 26 | $1,819 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 28 | $1,405 | $24 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,386 | $73 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 23 | $1,308 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 58 | $1,163 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $824 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 58 | $759 | $12 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 22 | $658 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $329 | $7 |
| Ultrasonic guidance for blood vessel access | 22 | $285 | $12 |
| Infusion, normal saline solution, 250 cc | 150 | $243 | None |
2015: 37 services
| Return visit (30+ min) | 528 | $126,645 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 127 | $60,387 | $472 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $50,493 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $42,577 | $62 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 127 | $33,838 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $22,524 | $173 |
| Injection, regadenoson, 0.1 mg | 88 | $14,751 | None |
| Short return visit (20+ min) | 124 | $10,062 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 37 | $9,340 | $252 |
| New patient visit (45+ min) | 64 | $9,038 | $141 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $8,462 | $242 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 133 | $8,250 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $8,146 | $55 |
| Initial hospital observation care per day, typically 70 minutes | 46 | $7,590 | $158 |
| Long return visit (40+ min) | 51 | $7,097 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,196 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 271 | $5,450 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 526 | $4,355 | $7 |
| Critical care, first 30-74 minutes | 15 | $3,420 | $190 |
| Programming of dual lead pacemaker system | 40 | $3,083 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 36 | $2,985 | $79 |
| Transitional care management services for problem of at least moderate complexity | 18 | $2,837 | $149 |
| Follow-up observation care per day, typically 25 minutes | 30 | $2,260 | $63 |
| Ultrasound of both sides of head and neck blood flow | 11 | $2,158 | $196 |
| New patient visit (60+ min) | 11 | $1,889 | $172 |
| Programming of multiple lead pacemaker system | 17 | $1,243 | $62 |
| Programming of dual lead implantable defibrillator system | 11 | $1,237 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 53 | $1,009 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $992 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 24 | $979 | $25 |
| Hospital observation care on day of discharge | 11 | $698 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 53 | $658 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $619 | $28 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $482 | $23 |
| Ultrasound of heart, follow-up | 12 | $269 | $22 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $249 | $12 |
| Infusion, normal saline solution, 250 cc | 128 | $157 | None |
2014: 33 services
| Return visit (30+ min) | 490 | $131,123 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 116 | $55,865 | $466 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $54,666 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 186 | $40,290 | $62 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 115 | $31,136 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $22,243 | $174 |
| Injection, regadenoson, 0.1 mg | 74 | $12,675 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $9,030 | $502 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | $8,767 | $55 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $8,133 | $262 |
| Short return visit (20+ min) | 104 | $7,659 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 119 | $7,567 | $61 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $6,286 | $190 |
| New patient visit (45+ min) | 41 | $5,766 | $141 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 263 | $5,144 | $15 |
| Long return visit (40+ min) | 31 | $4,708 | $127 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 49 | $4,553 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 482 | $4,130 | $7 |
| Programming of dual lead pacemaker system | 42 | $4,044 | $51 |
| Long return visit (40+ min) | 32 | $3,050 | $95 |
| Critical care, first 30-74 minutes | 11 | $2,840 | $189 |
| Ultrasound of both sides of head and neck blood flow | 14 | $2,587 | $185 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 18 | $2,150 | $22 |
| Programming of multiple lead implantable defibrillator system | 11 | $2,024 | $78 |
| Follow-up observation care per day, typically 25 minutes | 25 | $1,999 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,875 | $89 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,716 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 25 | $1,387 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $864 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $704 | $28 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 14 | $670 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 43 | $567 | $13 |
| Infusion, normal saline solution, 250 cc | 115 | $123 | None |
2013: 29 services
| Return visit (30+ min) | 498 | $128,580 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 208 | $58,278 | $60 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 95 | $46,505 | $484 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 186 | $32,430 | $172 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 95 | $25,440 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $21,974 | $169 |
| Injection, regadenoson, 0.1 mg | 59 | $10,115 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $8,629 | $54 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $7,610 | $211 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 99 | $6,481 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 714 | $5,938 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,506 | $196 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 199 | $3,877 | $16 |
| Programming of dual lead pacemaker system | 46 | $3,656 | $47 |
| Initial hospital observation care per day, typically 70 minutes | 18 | $2,947 | $155 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $2,935 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,616 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,438 | $87 |
| Follow-up observation care per day, typically 25 minutes | 35 | $2,429 | $59 |
| Critical care, first 30-74 minutes | 13 | $2,405 | $185 |
| New patient visit (45+ min) | 16 | $2,233 | $140 |
| New patient visit (60+ min) | 16 | $2,134 | $133 |
| Short return visit (20+ min) | 33 | $2,023 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 18 | $1,442 | $26 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $1,336 | $20 |
| Long return visit (40+ min) | 13 | $1,201 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 54 | $1,017 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 54 | $675 | $12 |
| Infusion, normal saline solution, 250 cc | 95 | $64 | None |
Medicaid work
$13,740 in 2024
Medicaid paid $13,740 for 791 billed services this clinician did in 2024, up to 105 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 108 | $7,993 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 632 | $3,278 |
| Return visit (30+ min) | 51 | $2,470 |
| 2024 | 791 | 3 | 105 | $13,740 |
| 2023 | 810 | 3 | 110 | $7,544 |
| 2022 | 608 | 2 | 69 | $4,185 |
| 2021 | 555 | 1 | 66 | $2,844 |
| 2020 | 282 | 1 | 48 | $1,234 |
| 2019 | 352 | 2 | 54 | $2,023 |
| 2018 | 215 | 1 | 43 | $901 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 125 | $4,130 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 672 | $3,320 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $93 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 569 | $2,950 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 39 | $1,235 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 555 | $2,844 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 282 | $1,234 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 338 | $1,788 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $235 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 215 | $901 |
Drugs they prescribed that Part D paid
$1,268,850
Pharmacies billed $1,268,850 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 10,017) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
8,983 generic and 1,034 brand-name prescriptions · $1,268,850 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 461 | $601,960 | $1,306 |
| Xarelto | 161 | $222,944 | $1,385 |
| Entresto | 65 | $71,751 | $1,104 |
| Jardiance | 55 | $69,979 | $1,272 |
| Brilinta | 22 | $22,595 | $1,027 |
See all 81 drugs
| Eliquis | 461 | $601,960 | $1,306 |
| Xarelto | 161 | $222,944 | $1,385 |
| Entresto | 65 | $71,751 | $1,104 |
| Jardiance | 55 | $69,979 | $1,272 |
| Brilinta | 22 | $22,595 | $1,027 |
| Repatha Sureclick | 20 | $21,845 | $1,092 |
| Farxiga | 21 | $19,959 | $950 |
| Metoprolol | 1,226 | $16,878 | $14 |
| Atorvastatin | 1,129 | $12,396 | $11 |
| Vascepa | 18 | $12,318 | $684 |
| Rosuvastatin | 651 | $12,237 | $19 |
| Ezetimibe | 285 | $8,701 | $31 |
| Dabigatran Etexilate | 25 | $7,615 | $305 |
| Diltiazem 24hr Er (Cd) | 213 | $7,115 | $33 |
| Losartan | 666 | $6,071 | $9 |
| Amlodipine Besylate | 677 | $4,807 | $7 |
| Omega-3 Acid Ethyl Esters | 42 | $4,715 | $112 |
| Olmesartan-Hydrochlorothiazide | 68 | $3,616 | $53 |
| Flecainide Acetate | 79 | $3,224 | $41 |
| Carvedilol | 326 | $3,010 | $9 |
| Bumetanide | 53 | $2,969 | $56 |
| Propafenone | 30 | $2,713 | $90 |
| Levothyroxine | 207 | $2,601 | $13 |
| Potassium Chloride | 133 | $2,574 | $19 |
| Lisinopril | 361 | $2,459 | $7 |
| Clonidine | 13 | $2,427 | $187 |
| Losartan-Hydrochlorothiazide | 165 | $2,379 | $14 |
| Isosorbide Mononitrate Er | 129 | $2,184 | $17 |
| Hydralazine | 107 | $2,095 | $20 |
| Midodrine | 21 | $2,088 | $99 |
| Ranolazine Er | 11 | $1,940 | $176 |
| Amlodipine-Olmesartan | 13 | $1,901 | $146 |
| Bisoprolol | 34 | $1,772 | $52 |
| Clopidogrel | 160 | $1,746 | $11 |
| Furosemide | 262 | $1,742 | $7 |
| Valsartan | 76 | $1,667 | $22 |
| Telmisartan | 35 | $1,622 | $46 |
| Nebivolol | 20 | $1,589 | $79 |
| Olmesartan Medoxomil | 82 | $1,558 | $19 |
| Colchicine | 26 | $1,549 | $60 |
| Amlodipine Besylate-Benazepril | 71 | $1,526 | $21 |
| Diltiazem 24hr Er | 27 | $1,517 | $56 |
| Prasugrel | 20 | $1,476 | $74 |
| Amiodarone | 119 | $1,462 | $12 |
| Valsartan-Hydrochlorothiazide | 20 | $1,269 | $63 |
| Nitroglycerin | 98 | $1,226 | $13 |
| Pravastatin | 103 | $1,222 | $12 |
| Synthroid | 17 | $946 | $56 |
| Triamterene-Hydrochlorothiazid | 102 | $896 | $9 |
| Amlodipine-Valsartan | 19 | $895 | $47 |
| Spironolactone | 121 | $854 | $7 |
| Labetalol | 22 | $824 | $37 |
| Digoxin | 25 | $784 | $31 |
| Dilt-Xr | 13 | $707 | $54 |
| Diltiazem 24hr Er (Xr) | 15 | $655 | $44 |
| Diltiazem | 33 | $651 | $20 |
| Pantoprazole | 44 | $615 | $14 |
| Fenofibrate | 21 | $581 | $28 |
| Cartia Xt | 19 | $560 | $29 |
| Atenolol | 80 | $543 | $7 |
| Metoprolol | 86 | $534 | $6 |
| Fenofibrate | 13 | $485 | $37 |
| Benazepril | 40 | $483 | $12 |
| Verapamil Er | 18 | $474 | $26 |
| Allopurinol | 36 | $437 | $12 |
| Chlorthalidone | 33 | $406 | $12 |
| Famotidine | 22 | $362 | $16 |
| Felodipine Er | 11 | $360 | $33 |
| Lovastatin | 28 | $353 | $13 |
| Hydrochlorothiazide | 44 | $343 | $8 |
| Ramipril | 44 | $310 | $7 |
| Simvastatin | 47 | $307 | $7 |
| Clonidine | 57 | $285 | $5 |
| Omeprazole | 17 | $277 | $16 |
| Warfarin | 32 | $190 | $6 |
| Fenofibrate | 15 | $166 | $11 |
| Irbesartan-Hydrochlorothiazide | 13 | $107 | $8 |
| Irbesartan | 18 | $33 | $2 |
| Metformin | 18 | $31 | $2 |
| Lisinopril-Hydrochlorothiazide | 12 | $29 | $2 |
| Amoxicillin | 17 | $18 | $1 |
Year by year
| 2024 | 10,017 | 1,041 | 0% (0) | 10% | $1,268,850 |
| 2023 | 8,735 | 936 | 0% (0) | 10% | $1,213,996 |
| 2022 | 8,267 | 832 | 0% (0) | 10% | $1,050,296 |
| 2021 | 8,086 | 783 | 0% (0) | 12% | $966,789 |
| 2020 | 7,387 | 732 | 0% (0) | 15% | $910,985 |
| 2019 | 6,890 | 704 | 0% (0) | 17% | $824,870 |
| 2018 | 6,933 | 648 | 0% (0) | 18% | $710,735 |
| 2017 | 7,401 | 614 | 0% (0) | 22% | $587,130 |
| 2016 | 6,821 | 608 | 0% (0) | None | $527,337 |
| 2015 | 6,047 | 545 | None | 25% | $436,960 |
| 2014 | 5,665 | 557 | None | None | $423,803 |
| 2013 | 5,355 | 533 | None | None | $366,360 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 79 drugs
| Eliquis | 408 | $558,840 | $1,370 |
| Xarelto | 199 | $255,329 | $1,283 |
| Jardiance | 29 | $37,584 | $1,296 |
| Entresto | 28 | $34,760 | $1,241 |
| Metoprolol | 1,116 | $23,451 | $21 |
| Multaq | 11 | $22,376 | $2,034 |
| Repatha Sureclick | 11 | $15,426 | $1,402 |
| Brilinta | 13 | $15,106 | $1,162 |
| Atorvastatin | 1,011 | $15,061 | $15 |
| Rosuvastatin | 501 | $14,607 | $29 |
| Farxiga | 14 | $13,299 | $950 |
| Diltiazem 24hr Er (Cd) | 185 | $10,262 | $55 |
| Losartan | 600 | $9,488 | $16 |
| Ezetimibe | 187 | $9,226 | $49 |
| Potassium Chloride | 135 | $7,943 | $59 |
| Icosapent Ethyl | 11 | $6,761 | $615 |
| Omega-3 Acid Ethyl Esters | 30 | $6,334 | $211 |
| Dabigatran Etexilate | 18 | $6,243 | $347 |
| Amlodipine Besylate | 535 | $5,587 | $10 |
| Carvedilol | 334 | $4,598 | $14 |
| Olmesartan-Hydrochlorothiazide | 67 | $4,573 | $68 |
| Clonidine | 15 | $4,260 | $284 |
| Losartan-Hydrochlorothiazide | 155 | $4,115 | $27 |
| Propafenone Hcl Er | 21 | $3,820 | $182 |
| Flecainide Acetate | 66 | $3,508 | $53 |
| Propafenone | 32 | $3,492 | $109 |
| Isosorbide Mononitrate Er | 129 | $3,396 | $26 |
| Ranolazine Er | 15 | $3,258 | $217 |
| Lisinopril | 324 | $3,146 | $10 |
| Levothyroxine | 177 | $3,115 | $18 |
| Bumetanide | 47 | $2,793 | $59 |
| Telmisartan | 38 | $2,737 | $72 |
| Hydralazine | 117 | $2,480 | $21 |
| Valsartan | 59 | $2,478 | $42 |
| Olmesartan Medoxomil | 61 | $2,273 | $37 |
| Clopidogrel | 120 | $2,171 | $18 |
| Furosemide | 245 | $2,160 | $9 |
| Amiodarone | 105 | $2,006 | $19 |
| Midodrine | 16 | $2,003 | $125 |
| Nebivolol | 17 | $1,780 | $105 |
| Dilt-Xr | 25 | $1,648 | $66 |
| Amlodipine Besylate-Benazepril | 68 | $1,597 | $23 |
| Nitroglycerin | 98 | $1,566 | $16 |
| Bisoprolol | 22 | $1,246 | $57 |
| Diltiazem | 34 | $1,221 | $36 |
| Diltiazem 24hr Er | 22 | $1,101 | $50 |
| Pravastatin | 62 | $1,057 | $17 |
| Valsartan-Hydrochlorothiazide | 11 | $1,056 | $96 |
| Prasugrel | 13 | $1,046 | $80 |
| Triamterene-Hydrochlorothiazid | 66 | $970 | $15 |
| Spironolactone | 104 | $959 | $9 |
| Amlodipine-Olmesartan | 11 | $958 | $87 |
| Labetalol | 16 | $923 | $58 |
| Cartia Xt | 21 | $898 | $43 |
| Fenofibrate | 16 | $874 | $55 |
| Diltiazem 24hr Er (Xr) | 18 | $857 | $48 |
| Warfarin | 31 | $845 | $27 |
| Pantoprazole | 39 | $837 | $21 |
| Atenolol | 86 | $820 | $10 |
| Fenofibrate | 18 | $777 | $43 |
| Clonidine | 47 | $716 | $15 |
| Allopurinol | 46 | $708 | $15 |
| Ramipril | 53 | $677 | $13 |
| Verapamil Er | 13 | $624 | $48 |
| Propranolol | 12 | $617 | $51 |
| Benazepril | 38 | $533 | $14 |
| Simvastatin | 35 | $531 | $15 |
| Metoprolol | 72 | $530 | $7 |
| Amlodipine-Valsartan | 11 | $466 | $42 |
| Digoxin | 15 | $356 | $24 |
| Famotidine | 26 | $355 | $14 |
| Lovastatin | 22 | $336 | $15 |
| Hydrochlorothiazide | 42 | $278 | $7 |
| Metformin | 19 | $255 | $13 |
| Gabapentin | 11 | $250 | $23 |
| Fenofibrate | 12 | $246 | $21 |
| Omeprazole | 25 | $200 | $8 |
| Irbesartan | 16 | $67 | $4 |
| Amoxicillin | 18 | $29 | $2 |
2022: 71 drugs
| Eliquis | 389 | $480,779 | $1,236 |
| Xarelto | 176 | $228,960 | $1,301 |
| Metoprolol | 1,138 | $24,942 | $22 |
| Rosuvastatin | 480 | $20,051 | $42 |
| Brilinta | 14 | $17,059 | $1,218 |
| Farxiga | 18 | $16,307 | $906 |
| Repatha Sureclick | 11 | $14,638 | $1,331 |
| Atorvastatin | 943 | $12,661 | $13 |
| Vascepa | 19 | $11,605 | $611 |
| Ezetimibe | 153 | $9,416 | $62 |
| Diltiazem 24hr Er (Cd) | 154 | $9,111 | $59 |
| Clonidine | 29 | $8,371 | $289 |
| Losartan | 577 | $7,932 | $14 |
| Potassium Chloride | 144 | $5,792 | $40 |
| Omega-3 Acid Ethyl Esters | 38 | $5,665 | $149 |
| Propafenone Hcl Er | 15 | $4,617 | $308 |
| Propafenone | 34 | $4,597 | $135 |
| Ranolazine Er | 16 | $4,160 | $260 |
| Amlodipine Besylate | 522 | $4,156 | $8 |
| Carvedilol | 289 | $4,026 | $14 |
| Levothyroxine | 185 | $3,905 | $21 |
| Isosorbide Mononitrate Er | 133 | $3,459 | $26 |
| Flecainide Acetate | 43 | $3,442 | $80 |
| Losartan-Hydrochlorothiazide | 139 | $3,293 | $24 |
| Bumetanide | 45 | $3,183 | $71 |
| Olmesartan-Hydrochlorothiazide | 29 | $2,658 | $92 |
| Lisinopril | 279 | $2,498 | $9 |
| Amiodarone | 98 | $2,196 | $22 |
| Nebivolol | 11 | $2,098 | $191 |
| Hydralazine | 85 | $2,076 | $24 |
| Olmesartan Medoxomil | 60 | $1,943 | $32 |
| Telmisartan | 21 | $1,933 | $92 |
| Dilt-Xr | 36 | $1,931 | $54 |
| Nitroglycerin | 119 | $1,920 | $16 |
| Diltiazem 24hr Er | 28 | $1,826 | $65 |
| Furosemide | 238 | $1,603 | $7 |
| Clopidogrel | 100 | $1,577 | $16 |
| Pravastatin | 70 | $1,410 | $20 |
| Diltiazem | 29 | $1,400 | $48 |
| Triamterene-Hydrochlorothiazid | 84 | $1,338 | $16 |
| Bisoprolol | 21 | $1,296 | $62 |
| Fenofibrate | 32 | $1,230 | $38 |
| Diltiazem 24hr Er (Xr) | 33 | $1,188 | $36 |
| Valsartan | 29 | $1,181 | $41 |
| Fenofibrate | 23 | $1,135 | $49 |
| Verapamil Sr | 15 | $1,125 | $75 |
| Warfarin | 36 | $1,091 | $30 |
| Amlodipine Besylate-Benazepril | 50 | $1,089 | $22 |
| Pantoprazole | 58 | $1,020 | $18 |
| Digoxin | 21 | $824 | $39 |
| Spironolactone | 75 | $739 | $10 |
| Valsartan-Hydrochlorothiazide | 13 | $738 | $57 |
| Verapamil Er | 18 | $704 | $39 |
| Atenolol | 93 | $698 | $8 |
| Allopurinol | 45 | $680 | $15 |
| Metoprolol | 68 | $668 | $10 |
| Fenofibrate | 12 | $633 | $53 |
| Benazepril | 33 | $625 | $19 |
| Clonidine | 57 | $597 | $10 |
| Sotalol | 15 | $527 | $35 |
| Ramipril | 50 | $517 | $10 |
| Klor-Con 10 | 14 | $465 | $33 |
| Hydrochlorothiazide | 57 | $383 | $7 |
| Famotidine | 17 | $329 | $19 |
| Simvastatin | 28 | $276 | $10 |
| Omeprazole | 35 | $276 | $8 |
| Metformin | 17 | $188 | $11 |
| Lovastatin | 17 | $155 | $9 |
| Chlorthalidone | 12 | $154 | $13 |
| Irbesartan | 15 | $101 | $7 |
| Amoxicillin | 23 | $37 | $2 |
2021: 74 drugs
| Eliquis | 460 | $476,528 | $1,036 |
| Xarelto | 178 | $183,620 | $1,032 |
| Metoprolol | 1,150 | $28,838 | $25 |
| Multaq | 18 | $24,548 | $1,364 |
| Rosuvastatin | 367 | $17,443 | $48 |
| Entresto | 12 | $15,871 | $1,323 |
| Atorvastatin | 907 | $13,772 | $15 |
| Repatha Sureclick | 11 | $12,414 | $1,129 |
| Vascepa | 15 | $10,379 | $692 |
| Brilinta | 11 | $9,313 | $847 |
| Losartan | 558 | $7,762 | $14 |
| Diltiazem 24hr Er (Cd) | 112 | $6,863 | $61 |
| Ezetimibe | 88 | $6,783 | $77 |
| Propafenone | 48 | $5,565 | $116 |
| Potassium Chloride | 143 | $5,467 | $38 |
| Clonidine | 27 | $5,459 | $202 |
| Prasugrel | 14 | $4,341 | $310 |
| Bumetanide | 55 | $4,328 | $79 |
| Carvedilol | 294 | $3,910 | $13 |
| Losartan-Hydrochlorothiazide | 114 | $3,819 | $33 |
| Flecainide Acetate | 40 | $3,674 | $92 |
| Levothyroxine | 159 | $3,439 | $22 |
| Amlodipine Besylate | 526 | $3,347 | $6 |
| Isosorbide Mononitrate Er | 127 | $3,248 | $26 |
| Ranolazine Er | 23 | $3,149 | $137 |
| Fenofibrate | 29 | $2,747 | $95 |
| Omega-3 Acid Ethyl Esters | 17 | $2,638 | $155 |
| Dilt-Xr | 51 | $2,626 | $51 |
| Valsartan | 40 | $2,196 | $55 |
| Hydralazine | 97 | $2,097 | $22 |
| Telmisartan | 20 | $2,018 | $101 |
| Lisinopril | 279 | $2,006 | $7 |
| Amiodarone | 69 | $1,843 | $27 |
| Olmesartan Medoxomil | 43 | $1,838 | $43 |
| Bisoprolol | 21 | $1,830 | $87 |
| Diltiazem 24hr Er | 34 | $1,823 | $54 |
| Fenofibrate | 27 | $1,663 | $62 |
| Furosemide | 251 | $1,626 | $6 |
| Nitroglycerin | 105 | $1,556 | $15 |
| Clopidogrel | 114 | $1,445 | $13 |
| Pravastatin | 76 | $1,421 | $19 |
| Fenofibrate | 27 | $1,402 | $52 |
| Digoxin | 27 | $1,397 | $52 |
| Amlodipine Besylate-Benazepril | 47 | $1,383 | $29 |
| Verapamil Sr | 12 | $1,239 | $103 |
| Triamterene-Hydrochlorothiazid | 87 | $1,190 | $14 |
| Diltiazem | 14 | $1,163 | $83 |
| Propranolol Hcl Er | 12 | $1,106 | $92 |
| Pantoprazole | 66 | $974 | $15 |
| Olmesartan-Hydrochlorothiazide | 13 | $970 | $75 |
| Ramipril | 58 | $893 | $15 |
| Diltiazem 24hr Er (Xr) | 19 | $827 | $44 |
| Warfarin | 35 | $806 | $23 |
| Benazepril | 60 | $757 | $13 |
| Clonidine | 74 | $691 | $9 |
| Verapamil Er | 23 | $639 | $28 |
| Atenolol | 67 | $616 | $9 |
| Klor-Con 10 | 12 | $565 | $47 |
| Allopurinol | 31 | $555 | $18 |
| Irbesartan | 21 | $524 | $25 |
| Metoprolol | 64 | $456 | $7 |
| Sotalol | 11 | $455 | $41 |
| Famotidine | 21 | $382 | $18 |
| Gabapentin | 11 | $361 | $33 |
| Hydrochlorothiazide | 62 | $356 | $6 |
| Omeprazole | 38 | $339 | $9 |
| Chlorthalidone | 14 | $333 | $24 |
| Simvastatin | 52 | $301 | $6 |
| Spironolactone | 41 | $290 | $7 |
| Lovastatin | 13 | $183 | $14 |
| Metformin | 18 | $128 | $7 |
| Enalapril Maleate | 13 | $73 | $6 |
| Lisinopril-Hydrochlorothiazide | 13 | $65 | $5 |
| Amoxicillin | 14 | $23 | $2 |
2020: 72 drugs
| Eliquis | 409 | $388,804 | $951 |
| Xarelto | 223 | $200,494 | $899 |
| Metoprolol | 1,010 | $28,807 | $29 |
| Entresto | 28 | $23,713 | $847 |
| Brilinta | 40 | $22,104 | $553 |
| Multaq | 18 | $19,571 | $1,087 |
| Vascepa | 33 | $17,303 | $524 |
| Repatha Sureclick | 24 | $14,827 | $618 |
| Rosuvastatin | 311 | $14,243 | $46 |
| Atorvastatin | 746 | $14,130 | $19 |
| Diltiazem 24hr Er (Cd) | 92 | $11,083 | $120 |
| Bystolic | 20 | $9,131 | $457 |
| Losartan | 507 | $7,668 | $15 |
| Propafenone | 45 | $6,253 | $139 |
| Potassium Chloride | 180 | $6,187 | $34 |
| Ezetimibe | 54 | $4,686 | $87 |
| Bumetanide | 58 | $4,470 | $77 |
| Levothyroxine | 174 | $4,273 | $25 |
| Diltiazem 24hr Er | 55 | $4,158 | $76 |
| Losartan-Hydrochlorothiazide | 50 | $3,797 | $76 |
| Clonidine | 15 | $3,701 | $247 |
| Omega-3 Acid Ethyl Esters | 19 | $3,398 | $179 |
| Carvedilol | 274 | $3,130 | $11 |
| Amlodipine Besylate | 434 | $2,783 | $6 |
| Dilt-Xr | 51 | $2,738 | $54 |
| Isosorbide Mononitrate Er | 108 | $2,665 | $25 |
| Flecainide Acetate | 17 | $2,504 | $147 |
| Telmisartan | 19 | $2,283 | $120 |
| Lisinopril | 301 | $2,247 | $7 |
| Fenofibrate | 25 | $2,198 | $88 |
| Hydralazine | 99 | $2,135 | $22 |
| Fenofibrate | 22 | $2,086 | $95 |
| Valsartan | 29 | $1,985 | $68 |
| Clopidogrel | 131 | $1,930 | $15 |
| Fenofibrate | 30 | $1,897 | $63 |
| Metolazone | 16 | $1,590 | $99 |
| Bisoprolol | 21 | $1,570 | $75 |
| Amiodarone | 75 | $1,544 | $21 |
| Digoxin | 32 | $1,436 | $45 |
| Furosemide | 202 | $1,400 | $7 |
| Pravastatin | 64 | $1,385 | $22 |
| Nitroglycerin | 92 | $1,357 | $15 |
| Olmesartan Medoxomil | 38 | $1,290 | $34 |
| Irbesartan | 22 | $1,008 | $46 |
| Ramipril | 70 | $1,004 | $14 |
| Pantoprazole | 66 | $996 | $15 |
| Atenolol | 89 | $959 | $11 |
| Sotalol | 13 | $922 | $71 |
| Prasugrel | 13 | $820 | $63 |
| Olmesartan-Hydrochlorothiazide | 14 | $811 | $58 |
| Klor-Con 10 | 20 | $806 | $40 |
| Amlodipine Besylate-Benazepril | 25 | $789 | $32 |
| Clonidine | 73 | $776 | $11 |
| Verapamil Er | 23 | $751 | $33 |
| Triamterene-Hydrochlorothiazid | 45 | $750 | $17 |
| Cartia Xt | 18 | $717 | $40 |
| Warfarin | 38 | $697 | $18 |
| Benazepril | 57 | $678 | $12 |
| Metoprolol | 76 | $656 | $9 |
| Felodipine Er | 15 | $626 | $42 |
| Propranolol | 11 | $539 | $49 |
| Chlorthalidone | 13 | $480 | $37 |
| Verapamil | 12 | $425 | $35 |
| Famotidine | 22 | $387 | $18 |
| Spironolactone | 39 | $380 | $10 |
| Hydrochlorothiazide | 59 | $356 | $6 |
| Omeprazole | 23 | $355 | $15 |
| Lovastatin | 18 | $306 | $17 |
| Simvastatin | 45 | $237 | $5 |
| Allopurinol | 18 | $200 | $11 |
| Metformin | 22 | $151 | $7 |
| Metformin Hcl Er | 11 | $36 | $3 |
2019: 73 drugs
| Eliquis | 343 | $324,070 | $945 |
| Xarelto | 237 | $179,685 | $758 |
| Brilinta | 75 | $39,400 | $525 |
| Metoprolol | 847 | $27,691 | $33 |
| Entresto | 20 | $17,695 | $885 |
| Atorvastatin | 699 | $14,387 | $21 |
| Rosuvastatin | 224 | $14,370 | $64 |
| Multaq | 12 | $10,433 | $869 |
| Bystolic | 27 | $9,819 | $364 |
| Repatha Sureclick | 14 | $9,572 | $684 |
| Potassium Chloride | 162 | $7,103 | $44 |
| Ezetimibe | 57 | $6,630 | $116 |
| Vascepa | 15 | $6,566 | $438 |
| Propafenone | 50 | $5,217 | $104 |
| Diltiazem 24hr Er (Cd) | 66 | $5,156 | $78 |
| Losartan | 377 | $4,866 | $13 |
| Clonidine | 23 | $4,772 | $207 |
| Diltiazem 24hr Er | 65 | $4,039 | $62 |
| Levothyroxine | 163 | $3,792 | $23 |
| Amlodipine Besylate | 405 | $3,590 | $9 |
| Carvedilol | 273 | $3,564 | $13 |
| Bumetanide | 44 | $3,377 | $77 |
| Flecainide Acetate | 25 | $3,031 | $121 |
| Fenofibrate | 35 | $2,833 | $81 |
| Telmisartan | 31 | $2,750 | $89 |
| Omega-3 Acid Ethyl Esters | 15 | $2,716 | $181 |
| Lisinopril | 300 | $2,675 | $9 |
| Fenofibrate | 28 | $2,641 | $94 |
| Isosorbide Mononitrate Er | 89 | $2,466 | $28 |
| Clopidogrel | 135 | $2,162 | $16 |
| Prasugrel | 28 | $2,154 | $77 |
| Matzim La | 11 | $2,131 | $194 |
| Olmesartan Medoxomil | 25 | $2,103 | $84 |
| Dilt-Xr | 39 | $2,080 | $53 |
| Furosemide | 208 | $1,923 | $9 |
| Labetalol | 15 | $1,597 | $106 |
| Losartan-Hydrochlorothiazide | 87 | $1,403 | $16 |
| Digoxin | 26 | $1,235 | $48 |
| Nitroglycerin | 79 | $1,234 | $16 |
| Metoprolol | 131 | $1,203 | $9 |
| Bisoprolol | 18 | $1,202 | $67 |
| Atenolol | 89 | $1,170 | $13 |
| Cartia Xt | 30 | $1,130 | $38 |
| Valsartan | 19 | $1,053 | $55 |
| Metolazone | 12 | $1,034 | $86 |
| Ramipril | 73 | $1,029 | $14 |
| Warfarin | 54 | $990 | $18 |
| Chlorthalidone | 20 | $972 | $49 |
| Hydralazine | 43 | $969 | $23 |
| Pravastatin | 38 | $899 | $24 |
| Irbesartan | 12 | $898 | $75 |
| Toprol Xl | 20 | $840 | $42 |
| Propranolol Hcl Er | 11 | $793 | $72 |
| Fenofibrate | 15 | $781 | $52 |
| Verapamil Er | 28 | $780 | $28 |
| Simvastatin | 79 | $750 | $9 |
| Triamterene-Hydrochlorothiazid | 49 | $699 | $14 |
| Amiodarone | 44 | $699 | $16 |
| Pantoprazole | 48 | $696 | $14 |
| Olmesartan-Hydrochlorothiazide | 20 | $673 | $34 |
| Propranolol | 15 | $662 | $44 |
| Sotalol | 16 | $631 | $39 |
| Omeprazole | 26 | $621 | $24 |
| Amlodipine Besylate-Benazepril | 21 | $596 | $28 |
| Clonidine | 64 | $573 | $9 |
| Allopurinol | 26 | $508 | $20 |
| Spironolactone | 53 | $489 | $9 |
| Hydrochlorothiazide | 62 | $433 | $7 |
| Klor-Con 10 | 13 | $377 | $29 |
| Lovastatin | 21 | $328 | $16 |
| Benazepril | 28 | $280 | $10 |
| Famotidine | 20 | $242 | $12 |
| Metformin | 23 | $174 | $8 |
2018: 76 drugs
| Eliquis | 321 | $253,587 | $790 |
| Xarelto | 230 | $146,303 | $636 |
| Metoprolol | 796 | $29,537 | $37 |
| Brilinta | 49 | $29,199 | $596 |
| Atorvastatin | 708 | $14,895 | $21 |
| Rosuvastatin | 240 | $13,421 | $56 |
| Ranexa | 15 | $12,384 | $826 |
| Pradaxa | 12 | $12,309 | $1,026 |
| Entresto | 11 | $11,440 | $1,040 |
| Prasugrel | 17 | $9,389 | $552 |
| Ezetimibe | 47 | $9,025 | $192 |
| Clonidine | 41 | $8,263 | $202 |
| Bystolic | 26 | $7,515 | $289 |
| Potassium Chloride | 189 | $6,730 | $36 |
| Propafenone | 67 | $5,948 | $89 |
| Fenofibrate | 47 | $4,688 | $100 |
| Diltiazem 24hr Er (Cd) | 52 | $4,399 | $85 |
| Valsartan | 74 | $4,337 | $59 |
| Levothyroxine | 197 | $4,219 | $21 |
| Omega-3 Acid Ethyl Esters | 21 | $4,002 | $191 |
| Olmesartan Medoxomil | 28 | $3,673 | $131 |
| Fenofibrate | 54 | $3,173 | $59 |
| Losartan | 340 | $3,155 | $9 |
| Flecainide Acetate | 23 | $3,124 | $136 |
| Carvedilol | 266 | $3,041 | $11 |
| Clopidogrel | 176 | $2,986 | $17 |
| Bumetanide | 34 | $2,752 | $81 |
| Amlodipine Besylate | 328 | $2,678 | $8 |
| Matzim La | 16 | $2,575 | $161 |
| Diltiazem 24hr Er | 40 | $2,375 | $59 |
| Verapamil | 19 | $2,294 | $121 |
| Lisinopril | 269 | $2,255 | $8 |
| Isosorbide Mononitrate Er | 111 | $2,146 | $19 |
| Midodrine | 13 | $2,115 | $163 |
| Verapamil Er | 40 | $1,957 | $49 |
| Verapamil Sr | 13 | $1,810 | $139 |
| Labetalol | 11 | $1,741 | $158 |
| Furosemide | 243 | $1,623 | $7 |
| Nitroglycerin | 96 | $1,564 | $16 |
| Cartia Xt | 42 | $1,547 | $37 |
| Digoxin | 37 | $1,435 | $39 |
| Amiodarone | 47 | $1,372 | $29 |
| Atenolol | 110 | $1,304 | $12 |
| Metoprolol | 143 | $1,216 | $9 |
| Telmisartan | 18 | $1,208 | $67 |
| Toprol Xl | 14 | $1,119 | $80 |
| Metolazone | 12 | $1,103 | $92 |
| Warfarin | 58 | $1,088 | $19 |
| Propranolol Hcl Er | 17 | $1,066 | $63 |
| Losartan-Hydrochlorothiazide | 61 | $987 | $16 |
| Simvastatin | 96 | $935 | $10 |
| Valsartan-Hydrochlorothiazide | 26 | $905 | $35 |
| Taztia Xt | 11 | $886 | $81 |
| Pravastatin | 34 | $878 | $26 |
| Diltiazem 24hr Er (Xr) | 12 | $876 | $73 |
| Ramipril | 61 | $873 | $14 |
| Pantoprazole | 63 | $865 | $14 |
| Hydralazine | 55 | $822 | $15 |
| Triamterene-Hydrochlorothiazid | 53 | $736 | $14 |
| Bisoprolol | 14 | $700 | $50 |
| Omeprazole | 41 | $620 | $15 |
| Lovastatin | 30 | $609 | $20 |
| Chlorthalidone | 18 | $560 | $31 |
| Fenofibrate | 14 | $531 | $38 |
| Klor-Con 10 | 24 | $518 | $22 |
| Allopurinol | 30 | $510 | $17 |
| Hydrochlorothiazide | 64 | $507 | $8 |
| Clonidine | 50 | $456 | $9 |
| Spironolactone | 39 | $426 | $11 |
| Famotidine | 22 | $374 | $17 |
| Amlodipine Besylate-Benazepril | 11 | $372 | $34 |
| Sotalol | 17 | $361 | $21 |
| Benazepril | 37 | $337 | $9 |
| Klor-Con Sprinkle | 13 | $251 | $19 |
| Metformin | 15 | $135 | $9 |
| Lisinopril-Hydrochlorothiazide | 11 | $76 | $7 |
2017: 77 drugs
| Eliquis | 307 | $167,364 | $545 |
| Xarelto | 198 | $102,422 | $517 |
| Metoprolol | 917 | $30,599 | $33 |
| Brilinta | 43 | $22,121 | $514 |
| Effient | 33 | $17,078 | $518 |
| Rosuvastatin | 231 | $16,766 | $73 |
| Zetia | 25 | $15,088 | $604 |
| Atorvastatin | 796 | $14,854 | $19 |
| Entresto | 17 | $12,580 | $740 |
| Crestor | 19 | $8,987 | $473 |
| Ranexa | 11 | $8,732 | $794 |
| Bystolic | 24 | $8,413 | $351 |
| Diltiazem 24hr Er | 129 | $7,845 | $61 |
| Valsartan | 117 | $6,437 | $55 |
| Prasugrel | 13 | $5,966 | $459 |
| Ezetimibe | 22 | $5,702 | $259 |
| Potassium Chloride | 190 | $5,637 | $30 |
| Propafenone | 84 | $5,600 | $67 |
| Omega-3 Acid Ethyl Esters | 27 | $4,837 | $179 |
| Clonidine | 23 | $4,710 | $205 |
| Levothyroxine | 230 | $4,451 | $19 |
| Fenofibrate | 70 | $3,863 | $55 |
| Fenofibrate | 35 | $3,786 | $108 |
| Verapamil | 19 | $3,072 | $162 |
| Flecainide Acetate | 34 | $2,944 | $87 |
| Clopidogrel | 217 | $2,750 | $13 |
| Carvedilol | 264 | $2,549 | $10 |
| Lisinopril | 271 | $2,309 | $9 |
| Amlodipine Besylate | 384 | $2,157 | $6 |
| Losartan | 255 | $2,095 | $8 |
| Isosorbide Mononitrate Er | 133 | $1,970 | $15 |
| Matzim La | 12 | $1,746 | $146 |
| Metoprolol | 184 | $1,744 | $9 |
| Amiodarone | 51 | $1,663 | $33 |
| Digoxin | 32 | $1,627 | $51 |
| Nitroglycerin | 76 | $1,559 | $21 |
| Bumetanide | 19 | $1,549 | $82 |
| Telmisartan | 19 | $1,499 | $79 |
| Cartia Xt | 59 | $1,433 | $24 |
| Toprol Xl | 15 | $1,426 | $95 |
| Verapamil Er | 42 | $1,392 | $33 |
| Warfarin | 64 | $1,374 | $21 |
| Furosemide | 242 | $1,318 | $5 |
| Valsartan-Hydrochlorothiazide | 39 | $1,313 | $34 |
| Taztia Xt | 23 | $1,295 | $56 |
| Labetalol | 26 | $1,293 | $50 |
| Pravastatin | 44 | $1,185 | $27 |
| Diltiazem | 12 | $1,152 | $96 |
| Atenolol | 129 | $1,084 | $8 |
| Ramipril | 64 | $1,027 | $16 |
| Simvastatin | 105 | $970 | $9 |
| Propranolol | 14 | $947 | $68 |
| Hydralazine | 40 | $741 | $19 |
| Pantoprazole | 62 | $740 | $12 |
| Bisoprolol | 16 | $699 | $44 |
| Allopurinol | 21 | $685 | $33 |
| Sotalol | 22 | $648 | $29 |
| Triamterene-Hydrochlorothiazid | 62 | $589 | $10 |
| Losartan-Hydrochlorothiazide | 45 | $535 | $12 |
| Omeprazole | 47 | $464 | $10 |
| Lovastatin | 27 | $452 | $17 |
| Spironolactone | 35 | $421 | $12 |
| Chlorthalidone | 13 | $415 | $32 |
| Nitrostat | 14 | $401 | $29 |
| Klor-Con 10 | 16 | $386 | $24 |
| Amlodipine Besylate-Benazepril | 14 | $367 | $26 |
| Benazepril | 54 | $364 | $7 |
| Famotidine | 37 | $309 | $8 |
| Hydrochlorothiazide | 54 | $302 | $6 |
| Amlodipine-Valsartan | 13 | $259 | $20 |
| Clonidine | 32 | $234 | $7 |
| Jantoven | 12 | $229 | $19 |
| Minoxidil | 12 | $211 | $18 |
| Metformin | 23 | $180 | $8 |
| Fosinopril | 13 | $148 | $11 |
| Metformin Hcl Er | 16 | $79 | $5 |
| Gabapentin | 11 | $33 | $3 |
2016: 75 drugs
| Xarelto | 231 | $104,998 | $455 |
| Eliquis | 218 | $98,923 | $454 |
| Crestor | 152 | $59,005 | $388 |
| Metoprolol | 767 | $23,073 | $30 |
| Zetia | 44 | $22,734 | $517 |
| Brilinta | 41 | $15,503 | $378 |
| Ranexa | 14 | $13,529 | $966 |
| Atorvastatin | 686 | $13,337 | $19 |
| Propafenone Hcl Er | 36 | $11,747 | $326 |
| Rosuvastatin | 90 | $9,100 | $101 |
| Bystolic | 28 | $8,046 | $287 |
| Benicar | 16 | $6,394 | $400 |
| Valsartan | 90 | $6,378 | $71 |
| Potassium Chloride | 200 | $5,985 | $30 |
| Vytorin | 12 | $5,863 | $489 |
| Entresto | 11 | $5,801 | $527 |
| Diltiazem 24hr Er | 71 | $5,538 | $78 |
| Omega-3 Acid Ethyl Esters | 23 | $5,120 | $223 |
| Fenofibrate | 70 | $3,835 | $55 |
| Levothyroxine | 207 | $3,828 | $18 |
| Fenofibrate | 36 | $3,708 | $103 |
| Carvedilol | 301 | $2,837 | $9 |
| Propafenone | 66 | $2,554 | $39 |
| Clopidogrel | 173 | $2,302 | $13 |
| Isosorbide Mononitrate Er | 155 | $2,133 | $14 |
| Lisinopril | 266 | $1,995 | $7 |
| Fenofibrate | 18 | $1,957 | $109 |
| Warfarin | 107 | $1,945 | $18 |
| Amlodipine Besylate | 279 | $1,737 | $6 |
| Nitrostat | 65 | $1,691 | $26 |
| Digoxin | 27 | $1,579 | $58 |
| Verapamil Er | 49 | $1,571 | $32 |
| Losartan | 238 | $1,555 | $7 |
| Telmisartan | 16 | $1,496 | $94 |
| Pravastatin | 43 | $1,464 | $34 |
| Metoprolol | 176 | $1,414 | $8 |
| Diltiazem 24hr Cd | 45 | $1,410 | $31 |
| Flecainide Acetate | 39 | $1,382 | $35 |
| Verapamil | 22 | $1,352 | $61 |
| Ramipril | 64 | $1,352 | $21 |
| Simvastatin | 101 | $1,345 | $13 |
| Taztia Xt | 44 | $1,281 | $29 |
| Valsartan-Hydrochlorothiazide | 44 | $1,223 | $28 |
| Furosemide | 221 | $1,129 | $5 |
| Amlodipine Besylate-Benazepril | 23 | $1,025 | $45 |
| Atenolol | 140 | $1,007 | $7 |
| Sotalol | 32 | $892 | $28 |
| Hydralazine | 19 | $888 | $47 |
| Allopurinol | 33 | $749 | $23 |
| Pantoprazole | 73 | $714 | $10 |
| Synthroid | 11 | $705 | $64 |
| Cartia Xt | 19 | $704 | $37 |
| Famotidine | 44 | $644 | $15 |
| Chlorthalidone | 19 | $643 | $34 |
| Bisoprolol | 16 | $592 | $37 |
| Triamterene-Hydrochlorothiazid | 57 | $567 | $10 |
| Quinapril | 15 | $565 | $38 |
| Jantoven | 23 | $544 | $24 |
| Amiodarone | 24 | $540 | $22 |
| Propranolol | 13 | $480 | $37 |
| Omeprazole | 40 | $459 | $11 |
| Benazepril | 63 | $396 | $6 |
| Labetalol | 18 | $386 | $21 |
| Losartan-Hydrochlorothiazide | 36 | $363 | $10 |
| Lovastatin | 33 | $327 | $10 |
| Spironolactone | 31 | $321 | $10 |
| Nitroglycerin | 16 | $304 | $19 |
| Metformin | 31 | $298 | $10 |
| Minoxidil | 12 | $250 | $21 |
| Hydrochlorothiazide | 42 | $224 | $5 |
| Clonidine | 28 | $180 | $6 |
| Methimazole | 11 | $167 | $15 |
| Fosinopril | 13 | $160 | $12 |
| Lorazepam | 12 | $70 | $6 |
| Gabapentin | 13 | $35 | $3 |
2015: 68 drugs
| Xarelto | 209 | $83,557 | $400 |
| Eliquis | 165 | $64,507 | $391 |
| Crestor | 149 | $51,166 | $343 |
| Metoprolol | 576 | $19,669 | $34 |
| Ranexa | 26 | $15,539 | $598 |
| Atorvastatin | 630 | $13,406 | $21 |
| Zetia | 25 | $12,055 | $482 |
| Propafenone Hcl Er | 24 | $11,935 | $497 |
| Valsartan | 69 | $7,708 | $112 |
| Brilinta | 18 | $6,164 | $342 |
| Bystolic | 32 | $5,635 | $176 |
| Lovaza | 20 | $5,579 | $279 |
| Fenofibrate | 23 | $5,337 | $232 |
| Potassium Chloride | 164 | $4,813 | $29 |
| Omega-3 Acid Ethyl Esters | 18 | $4,607 | $256 |
| Levothyroxine | 225 | $4,527 | $20 |
| Diltiazem 24hr Er | 34 | $4,148 | $122 |
| Benicar | 18 | $4,141 | $230 |
| Fenofibrate | 67 | $3,487 | $52 |
| Warfarin | 194 | $3,477 | $18 |
| Propafenone | 82 | $3,455 | $42 |
| Fenofibrate | 25 | $3,362 | $134 |
| Metolazone | 12 | $2,857 | $238 |
| Carvedilol | 258 | $2,541 | $10 |
| Clopidogrel | 155 | $2,363 | $15 |
| Fenofibric Acid | 17 | $2,200 | $129 |
| Diltiazem 24hr Cd | 65 | $2,064 | $32 |
| Losartan | 203 | $2,053 | $10 |
| Ramipril | 86 | $1,898 | $22 |
| Isosorbide Mononitrate Er | 132 | $1,883 | $14 |
| Lisinopril | 250 | $1,805 | $7 |
| Pravastatin | 51 | $1,708 | $33 |
| Bumetanide | 12 | $1,529 | $127 |
| Valsartan-Hydrochlorothiazide | 42 | $1,430 | $34 |
| Verapamil Er | 43 | $1,298 | $30 |
| Amlodipine Besylate | 250 | $1,251 | $5 |
| Metoprolol | 161 | $1,213 | $8 |
| Quinapril | 31 | $1,207 | $39 |
| Taztia Xt | 18 | $1,169 | $65 |
| Digoxin | 20 | $1,121 | $56 |
| Furosemide | 191 | $1,086 | $6 |
| Hydralazine | 24 | $1,081 | $45 |
| Simvastatin | 118 | $1,059 | $9 |
| Atenolol | 108 | $1,056 | $10 |
| Flecainide Acetate | 21 | $968 | $46 |
| Sotalol | 27 | $954 | $35 |
| Amiodarone | 28 | $938 | $34 |
| Cartia Xt | 24 | $921 | $38 |
| Nitrostat | 56 | $829 | $15 |
| Verapamil | 20 | $761 | $38 |
| Diltiazem Er | 20 | $751 | $38 |
| Losartan-Hydrochlorothiazide | 46 | $650 | $14 |
| Labetalol | 18 | $584 | $32 |
| Allopurinol | 28 | $566 | $20 |
| Pantoprazole | 43 | $540 | $13 |
| Famotidine | 41 | $531 | $13 |
| Amlodipine Besylate-Benazepril | 16 | $455 | $28 |
| Benazepril | 64 | $436 | $7 |
| Omeprazole | 30 | $421 | $14 |
| Lovastatin | 29 | $418 | $14 |
| Triamterene-Hydrochlorothiazid | 23 | $312 | $14 |
| Metformin | 29 | $266 | $9 |
| Methimazole | 17 | $235 | $14 |
| Hydrochlorothiazide | 38 | $173 | $5 |
| Irbesartan | 11 | $153 | $14 |
| Spironolactone | 20 | $144 | $7 |
| Fosinopril | 13 | $107 | $8 |
| Gabapentin | 11 | $48 | $4 |
2014: 76 drugs
| Xarelto | 171 | $59,303 | $347 |
| Crestor | 158 | $49,652 | $314 |
| Eliquis | 107 | $33,028 | $309 |
| Propafenone Hcl Er | 37 | $22,099 | $597 |
| Diovan | 81 | $20,919 | $258 |
| Metoprolol | 520 | $20,514 | $39 |
| Ranexa | 19 | $13,821 | $727 |
| Brilinta | 40 | $11,031 | $276 |
| Atorvastatin | 511 | $10,909 | $21 |
| Zetia | 22 | $9,874 | $449 |
| Welchol | 17 | $9,587 | $564 |
| Niacin Er | 14 | $7,081 | $506 |
| Fenofibrate | 27 | $5,493 | $203 |
| Lovaza | 19 | $5,484 | $289 |
| Benicar | 20 | $4,892 | $245 |
| Potassium Chloride | 139 | $4,340 | $31 |
| Clopidogrel | 139 | $4,249 | $31 |
| Diltiazem 24hr Cd | 53 | $4,176 | $79 |
| Fenofibrate | 22 | $3,977 | $181 |
| Fenofibrate | 58 | $3,766 | $65 |
| Diltiazem 24hr Er | 40 | $3,654 | $91 |
| Levothyroxine | 230 | $3,343 | $15 |
| Carvedilol | 257 | $3,321 | $13 |
| Warfarin | 234 | $3,260 | $14 |
| Propafenone | 65 | $3,187 | $49 |
| Tribenzor | 13 | $3,134 | $241 |
| Valsartan-Hydrochlorothiazide | 42 | $3,011 | $72 |
| Fenofibric Acid | 18 | $2,962 | $165 |
| Telmisartan | 12 | $2,880 | $240 |
| Bystolic | 20 | $2,648 | $132 |
| Pravastatin | 75 | $2,412 | $32 |
| Exforge | 13 | $2,269 | $175 |
| Ramipril | 102 | $2,260 | $22 |
| Isosorbide Mononitrate Er | 142 | $2,182 | $15 |
| Amiodarone | 44 | $2,081 | $47 |
| Azor | 12 | $1,919 | $160 |
| Valsartan | 14 | $1,895 | $135 |
| Lisinopril | 221 | $1,797 | $8 |
| Amlodipine Besylate | 234 | $1,793 | $8 |
| Simvastatin | 133 | $1,564 | $12 |
| Metoprolol | 160 | $1,507 | $9 |
| Losartan | 102 | $1,358 | $13 |
| Taztia Xt | 23 | $1,298 | $56 |
| Synthroid | 21 | $1,278 | $61 |
| Quinapril | 21 | $1,268 | $60 |
| Toprol Xl | 15 | $1,172 | $78 |
| Digoxin | 13 | $1,127 | $87 |
| Atenolol | 96 | $966 | $10 |
| Verapamil Er | 29 | $821 | $28 |
| Sotalol | 30 | $815 | $27 |
| Nitrostat | 67 | $814 | $12 |
| Diltiazem Er | 22 | $771 | $35 |
| Furosemide | 148 | $719 | $5 |
| Omeprazole | 41 | $625 | $15 |
| Sildenafil | 12 | $620 | $52 |
| Verapamil | 18 | $614 | $34 |
| Doxazosin Mesylate | 12 | $590 | $49 |
| Famotidine | 41 | $520 | $13 |
| Benazepril | 52 | $507 | $10 |
| Lovastatin | 21 | $455 | $22 |
| Losartan-Hydrochlorothiazide | 26 | $447 | $17 |
| Pantoprazole | 33 | $397 | $12 |
| Hydralazine | 21 | $394 | $19 |
| Lisinopril-Hydrochlorothiazide | 12 | $282 | $23 |
| Meclizine | 20 | $270 | $14 |
| Allopurinol | 27 | $264 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $263 | $16 |
| Irbesartan | 16 | $253 | $16 |
| Metformin | 24 | $246 | $10 |
| Methimazole | 17 | $243 | $14 |
| Hydrochlorothiazide | 41 | $215 | $5 |
| Fosinopril | 15 | $213 | $14 |
| Sertraline | 26 | $213 | $8 |
| Zolpidem | 21 | $193 | $9 |
| Clonidine | 14 | $87 | $6 |
| Gabapentin | 13 | $62 | $5 |
2013: 74 drugs
| Crestor | 101 | $32,340 | $320 |
| Diovan | 151 | $29,751 | $197 |
| Xarelto | 88 | $27,172 | $309 |
| Metoprolol | 431 | $19,965 | $46 |
| Propafenone | 79 | $17,464 | $221 |
| Atorvastatin | 375 | $14,102 | $38 |
| Ranexa | 21 | $12,527 | $597 |
| Pradaxa | 23 | $10,172 | $442 |
| Zetia | 26 | $9,590 | $369 |
| Clopidogrel | 139 | $7,569 | $54 |
| Niaspan | 18 | $7,037 | $391 |
| Fenofibrate | 20 | $5,839 | $292 |
| Lovaza | 22 | $5,801 | $264 |
| Lipitor | 20 | $5,696 | $285 |
| Eliquis | 20 | $5,380 | $269 |
| Benicar | 22 | $4,964 | $226 |
| Valsartan-Hydrochlorothiazide | 47 | $4,957 | $105 |
| Carvedilol | 284 | $4,774 | $17 |
| Brilinta | 18 | $4,421 | $246 |
| Diltiazem 24hr Er | 55 | $4,213 | $77 |
| Trilipix | 14 | $4,080 | $291 |
| Tribenzor | 19 | $4,065 | $214 |
| Fenofibrate | 38 | $3,946 | $104 |
| Warfarin | 227 | $3,744 | $16 |
| Diltiazem 24hr Cd | 69 | $3,344 | $48 |
| Simvastatin | 214 | $2,897 | $14 |
| Amlodipine Besylate | 237 | $2,893 | $12 |
| Toprol Xl | 33 | $2,791 | $85 |
| Potassium Chloride | 95 | $2,760 | $29 |
| Pacerone | 19 | $2,725 | $143 |
| Losartan | 127 | $2,071 | $16 |
| Lisinopril | 229 | $2,001 | $9 |
| Isosorbide Mononitrate Er | 129 | $2,001 | $16 |
| Ramipril | 94 | $1,979 | $21 |
| Diltiazem Er | 26 | $1,962 | $75 |
| Azor | 12 | $1,940 | $162 |
| Pravastatin | 76 | $1,867 | $25 |
| Verapamil Er | 30 | $1,524 | $51 |
| Atenolol | 117 | $1,464 | $13 |
| Levothyroxine | 152 | $1,439 | $9 |
| Bystolic | 19 | $1,415 | $74 |
| Metoprolol | 132 | $1,377 | $10 |
| Sotalol | 31 | $1,207 | $39 |
| Omeprazole | 48 | $1,047 | $22 |
| Quinapril | 26 | $1,043 | $40 |
| Hydralazine | 26 | $949 | $37 |
| Fenofibrate | 11 | $886 | $81 |
| Furosemide | 154 | $819 | $5 |
| Labetalol | 13 | $773 | $59 |
| Verapamil | 11 | $664 | $60 |
| Nitrostat | 50 | $595 | $12 |
| Synthroid | 23 | $576 | $25 |
| Doxazosin Mesylate | 13 | $575 | $44 |
| Amiodarone | 47 | $573 | $12 |
| Famotidine | 49 | $566 | $12 |
| Benazepril | 56 | $561 | $10 |
| Klor-Con 10 | 14 | $462 | $33 |
| Klor-Con M20 | 13 | $460 | $35 |
| Bumetanide | 16 | $429 | $27 |
| Lovastatin | 17 | $428 | $25 |
| Nifedipine Er | 11 | $416 | $38 |
| Clonidine | 35 | $402 | $11 |
| Metformin | 29 | $319 | $11 |
| Losartan-Hydrochlorothiazide | 18 | $316 | $18 |
| Pantoprazole | 23 | $310 | $13 |
| Meclizine | 17 | $270 | $16 |
| Irbesartan | 15 | $265 | $18 |
| Zolpidem | 37 | $254 | $7 |
| Hydrochlorothiazide | 44 | $251 | $6 |
| Allopurinol | 39 | $239 | $6 |
| Triamterene-Hctz | 12 | $217 | $18 |
| Digox | 12 | $164 | $14 |
| Sertraline | 15 | $124 | $8 |
| Gabapentin | 13 | $75 | $6 |
Money from drug and device companies
$678 in 2025
| 2025 | 9 | 13 | None | $678 |
| 2024 | 6 | 13 | None | $656 |
| 2023 | 7 | 15 | None | $772 |
| 2022 | 6 | 12 | None | $550 |
| 2021 | 7 | 26 | None | $946 |
| 2020 | 7 | 12 | None | $520 |
| 2019 | 10 | 47 | None | $4,756 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Avvigo Guidance System | $324 | 4 payments
|
| CVRx | Barostim Neo System | $125 | 1 payment
|
| Abbott Laboratories | Aveir | $56 | 1 payment
|
| Stryker | Revcore Thrombectomy Catheter | $47 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $46 | 2 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 | 1 payment
|
See all 13 published payments
| Stryker | Meals · 2025-12-02 | Revcore Thrombectomy Catheter | $47 |
| Boston Scientific | Meals · 2025-11-24 | Lux-Dx Insertable Cardiac Monitor | $18 |
| CVRx | Meals · 2025-10-14 | Barostim Neo System | $125 |
| Philips North America | Meals · 2025-10-07 | Angio Ifr | $14 |
| Boston Scientific | Meals · 2025-09-17 | Avvigo Guidance System | $148 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-06 | Lifevest | $24 |
| Shockwave Medical | Meals · 2025-07-10 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 |
| Boston Scientific | Meals · 2025-06-12 | Emblem Mri S-Icd | $89 |
| Abbott Laboratories | Meals · 2025-06-12 | Aveir | $56 |
| Biotronik | Meals · 2025-05-21 | Amvia Edge | $21 |
| Boston Scientific | Meals · 2025-04-04 | Lux-Dx Insertable Cardiac Monitor | $69 |
| Heartflow | Meals · 2025-03-19 | Ffrct | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-13 | Lifevest | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $656
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $282 | 4 payments
|
| Boston Scientific | Watchman Flx | $244 | 3 payments
|
| Philips North America | (Bq9) Coronary Ivus | $42 | 2 payments
|
| Medtronic | Venaseal | $40 | 2 payments
|
| Cardiac Dimensions | None | $32 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $15 | 1 payment
|
2023: $772
| Abiomed | Impella | $308 | 3 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $210 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $99 | 1 payment
|
| Abbott Laboratories | Perclose Prostyle | $59 | 1 payment
|
| Philips Electronics North America | (6585) Omniwire | $54 | 3 payments
|
| Medtronic | Micra | $22 | 1 payment
|
| Atricure | Atriclip Laa Exclusion System | $20 | 1 payment
|
2022: $550
| Abiomed | Impella | $284 | 3 payments
|
| Boston Scientific | Emblem Mri S-Icd | $132 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $59 | 4 payments
|
| Biotronik | Biomonitor | $28 | 1 payment
|
| Abbott Laboratories | Optis | $25 | 1 payment
|
| Getinge USA Sales | Cardiosave Hybrid, Type B Plug | $22 | 1 payment
|
2021: $946
| Abiomed | Impella | $282 | 8 payments
|
| Boston Scientific | Emblem | $200 | 4 payments
|
| Abbott Laboratories | Optis Coronary Imaging System | $176 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $122 | 2 payments
|
| Medtronic | Endurant | $116 | 1 payment
|
| Biotronik | Solia | $29 | 1 payment
|
| Philips Electronics North America | (6571) Eagle Eye | $21 | 1 payment
|
2020: $520
| Abbott Laboratories | Dragonfly Oct | $201 | 4 payments
|
| Boston Scientific | Latitude | $126 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $125 | 1 payment
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $25 | 1 payment
|
| Biotronik | None | $16 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $15 | 1 payment
|
| Amarin Pharma | Vascepa | $13 | 1 payment
|
2019: $4,756
| Abbott Laboratories | Xience V Coronary Stent System | $1,806 | 17 payments
|
| Boston Scientific | General Therapies | $1,750 | 18 payments
|
| Corindus | Corpath Grx | $875 | 4 payments
|
| Abiomed | Impella | $145 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $110 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 2 payments
|
| Roche Diagnostics | Cd Cobas Reagents | $15 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $13 | 1 payment
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $13 | 1 payment
|
| Biotronik | None | $12 | 1 payment
|
Professional record
- NPI
- 1235227109
- Licence
- CA A52480California A52480: Current · expires 2027-06-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A52480
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 5565 W Las Positas Blvd Ste 150, Pleasanton, CA, 94588
- NPI first listed
- 2006-10-10
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.